• What corrective actions could you recommend be implemented to address the root causes of the conflict that you previously determined?
• What types of quantifiable metrics can you propose to measure progress in implementing the recommended corrective actions?
• What are three potential areas of resistance to your recommended corrective actions, and what ameliorative suggestions can you offer to reduce such resistance?
• How effective are the various leadership styles on employee engagement and employee empowerment in the case study?
• How has your experience with the team-building process from Tuckman’s theory of group formation dynamics informed your Improve recommendations? Further, what are your thoughts on the value of implementing Tuckman’s five areas of group formation dynamics in preventing some of the issues with the dysfunctional team in the case study?
• What are some effective leadership styles and team-building processes that organizational leadership could use to promote increased employee engagement and foster collaboration?
approves drugs but what makes their system different is that they have a separate body called the National Institute for Health and Social Care Excellence (NICE) who is responsible for determining a drug’s cost effectiveness and clinical benefits(Nawrat). Canada also utilizes a single-payer system for healthcare is therefore in control of the country’s drug prices (Amadeo). Canada established a Patented Medicine Prices Review Board that encourages pharmaceutical companies to suggest a price proposal for their manufactured drugs. This review board then compares the suggested price to various other countries with similar drugs. Approval is made depending on the cost of the drugs in other countries. Despite Canada’s single payer system, the country lacks universal drug coverage but due to their current system, the costs of prescription drugs in Canada remain cheaper than the cost in the United States (Morgan et al). In addition, Spain is another country that continuously aims to lower drug prices by utilizing reference pricing. Reference pricing is a system in which similar of identical drugs are categorized into a class. This allows for the insurer to pay one price for any of the drugs included within the given class. However, a pharmaceutical companies in Spain have the option of increasing drug costs thus requiring individuals to pay the difference between insurer costs and pharmaceutical company demands. Despite this, Spain has found that reference pricing often forces pharmaceutical companies to lower prices in order to maintain consumer business. Reference pricing has greatly assisted with cost-effectiveness by selling normally high-priced drugs at a reduced price (Frakt). Constructing alternatives>GET ANSWER